Geospatial disparities, health system factors, and breast cancer care quality
JNCI Cancer Spectrum · 2025
DOI: 10.1093/jncics/pkaf089 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI Cancer Spectrum, 2025. Verfasst von Michael J Hassett und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States. Hauptthemen laut MEDLINE: Breast Neoplasms, Healthcare Disparities, Quality of Health Care. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, DFCI Nodal Award Program, American Cancer Society Grant.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Despite long-standing efforts to improve breast cancer care quality, wide performance gaps persist. We sought to identify regions demonstrating meaningfully low performance and characterize health-system and health-profession factors associated with geospatial disparities.
Methods
We used the Surveillance, Epidemiology, and End Results–Medicare linked database and the Health Resources and Services Administration area health resource file to characterize performance across health-care service areas using 4 metrics: diagnosis stage, chemotherapy, radiation, and endocrine therapy. We used principal component analysis to identify health-care facility and provider characteristics associated with performance; and hierarchical multivariable modeling to attribute total variance proportionally to 5 domains: patient characteristics, health service area region, health-care facility and provider characteristics, randomness, and unexplained.
Results
Among 31,571 women aged 66-79 diagnosed 2007-2013 with stage I-III breast cancer and treated with surgery, 61% had stage I disease, 23% received chemotherapy, 54% received radiation therapy, and 42% received endocrine therapy. Health system factors explained more variance for endocrine therapy (21%), chemotherapy (12%), and radiation therapy (12%), compared with geospatial region or patient characteristics. Health profession factors were associated with quality for stage, radiation therapy, and chemotherapy; health-care facility factors were associated with quality for stage, endocrine therapy, and chemotherapy. Patient characteristics explained <5% of observed variance.
Conclusions
Reassuringly, only a small number of regions demonstrated suboptimal breast cancer care. Optimal performance was associated with multidisciplinary teams and facilities with robust resources and higher volumes. Incorporating geospatial and health system factors into quality measurement efforts could foster the design of impactful quality improvement programs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.
- Harvard Medical School, Harvard University, Boston, MA, United States.
- Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, United States.
- Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, United States.
- Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham & Women's Hospital, Boston, MA, United States.
ORCID-Profile: Michael J Hassett, Angela C Tramontano, Hajime Uno, Debra P Ritzwoller, Rinaa S Punglia
Förderung
- NCI NIH HHS
- DFCI Nodal Award Program
- American Cancer Society Grant
- NIGMS NIH HHS
Zitieren
APA
Hassett, M. J., Tramontano, A. C., Uno, H., Ritzwoller, D. P., & Punglia, R. S. (2025). Geospatial disparities, health system factors, and breast cancer care quality. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkaf089
Vancouver
Hassett MJ, Tramontano AC, Uno H, Ritzwoller DP, Punglia RS. Geospatial disparities, health system factors, and breast cancer care quality. JNCI Cancer Spectrum. 2025. doi:10.1093/jncics/pkaf089
BibTeX
@article{Hassett2025,
author = {Hassett, Michael J and Tramontano, Angela C and Uno, Hajime and Ritzwoller, Debra P and Punglia, Rinaa S},
title = {Geospatial disparities, health system factors, and breast cancer care quality},
journal = {JNCI Cancer Spectrum},
year = {2025},
doi = {10.1093/jncics/pkaf089}
}
EUVIMED